Ned is a senior editor for BioPharma Dive. Before joining Industry Dive, Ned covered economic news for a Japanese newswire and contributed articles on political risk for Global Risk Insights. He has a B.A. from the College at Georgetown University. Hoya Saxa.
1343 ARTICLES BY Ned Pagliarulo
-
Soon to depart, Scott Gottlieb keeps focus on greater drug competition
March 20, 2019 -
Roche's Tecentriq secures another immunotherapy first
March 19, 2019 -
Gene therapy progress spurs competition in biotech buyouts
March 19, 2019 -
Heart benefits to AstraZeneca's Farxiga detailed in new findings
March 18, 2019 -
FDA's Gottlieb calls for greater adoption of new clinical trial tools
March 15, 2019 -
Celgene dodges Alvogen bid to overturn Revlimid patent
March 14, 2019 -
Amgen's top-selling Enbrel in balance as key court ruling nears
March 13, 2019 -
NCI Director Ned Sharpless to become acting FDA commissioner
March 12, 2019 -
Biogen sells biologics plant to Fujifilm in $890M deal
March 12, 2019 -
Roche wins first immunotherapy approval for triple-negative breast cancer
March 8, 2019 -
Mylan's Advair generic pressures GSK with strong launch
March 8, 2019 -
FDA walks back plan to alter generic names of already approved biologics
March 7, 2019 -
Allergan depression drug fails in setback for turnaround
March 7, 2019 -
FDA approves J&J's esketamine as faster-acting depression treatment
March 6, 2019 -
Gilead oncology chief departing to head up Glenmark spin-out
March 5, 2019 -
FDA Commissioner Scott Gottlieb resigning, to leave in one month
March 5, 2019 -
Celgene checks regulatory box for key drug in Bristol-Myers deal
March 5, 2019 -
Lilly to launch generic of its insulin Humalog, cutting list price in half
March 4, 2019 -
Aimmune has its answer on peanut drug's status, but how FDA proceeds still unclear
March 1, 2019 -
Roche wins US approval of more convenient Herceptin
March 1, 2019 -
At Senate hearing, pharma shows split on biosimilars
Feb. 27, 2019 -
Gene therapy progress spurs Sarepta buy of Myonexus
Feb. 27, 2019 -
Pharma's day in Congress: 'A hearing not a show'
Feb. 26, 2019 -
In front of Congress, pharma execs blame 'broken' system
Feb. 26, 2019 -
Amgen wins jury verdict in PCSK9 court battle with Sanofi, Regeneron
Feb. 25, 2019